Generous donors fund institute's summer interns

Philanthropy fuels the Taubman Institute’s mission of funding talented, proven clinician-scientists at U-M, and their promising junior counterparts, through grant programs that support these physicians’ laboratory research.

And now, generous donors have made it possible to teach and encourage the medical science leaders of tomorrow.  Michigan philanthropists Joel and Shelley Tauber, longtime U-M supporters and members of the Taubman Institute’s Leadership Advisory Board, are the benefactors of the institute’s newest initiative, the Tauber Family Student Internship Program.  

This five-year financial commitment will finance three student internships each year, allowing undergraduate students to work within the laboratories of Taubman Scholars or Emerging Scholars.  It’s hoped that the exposure to cutting-edge translational medical research will encourage these budding scientists to choose a lifetime of striving to bring new cures and treatments to patients with difficult diseases.

“When young, imagining a future for oneself can be overwhelming,” the Taubers said.  “We want to be part of inspiring young people to pursue a future in medical research by exposing them to Michigan's scientific environment.

“Our goal is to enable interested and qualified young students to be part of teams that are focused on understanding and advancing medicine and its ability to treat disease.”

For 2013, three students will assist in the Program for Neurology Research & Discovery, the laboratory of Taubman Institute Director Dr. Eva Feldman.  They are:

•    Anna Bakeman, a student at the Medical College of Wisconsin
•    Rebecca Glasser, a student at Harvard University
•    Zachary Kelly, a student at Emory University

All of the interns will have an opportunity to work on projects ranging from stem cell derivation to the analysis of skin samples taken from neurology patients.  

Rebecca Glasser, a West Bloomfield, Mich. native and a sophomore studying molecular and cellular biology at Harvard, says the internship meshes with her career aspiration to work as a clinician-scientist.

“Working in the lab is a manifestation of everything I’ve learned in school,” she said.  “It’s great to actually see how everything comes together in the lab, rather than just in a textbook.  It’s really given me perspective on what I want to do.”

 


Help Us Make A Difference. Make A Donation That Could Save Lives.

Make A Gift

Connect/
Share/
follow/

Follow Us / Friend Us

Discovery-driven research that matters

phallodin

Taubman Scholar Dr. Charles Burant tests promising diabetes drug

TAK-875, a new treatment for type 2 diabetes, improves blood sugar control and is equally effective as glimepiride, but has a significantly lower risk of creating a dangerous drop in blood sugar, called hypoglycemia, according to a new study.

Read more

Taubman Institute leaders make the case for more doctor-scientist funding

 

The prestigious "Academic Medicine" journal has just published a new article authored by Taubman Institute senior management and Detroit-area attorney Scott Roberts.

The article explores the problematic gap between bench research and clinical application of new treatments or cures. 

Read more


Help Us Make A Difference. Make A Gift.

Leaders from the realms of business, academia and the community help to refine the Taubman Institute's vision, to monitor progress and to provide support, advice and counsel.

Meet the Leadership Advisory Board

Meet the Scientific Advisory Board

About Taubman Institute Video

In this video feature, Taubman Scholars explain why funding for high-risk research is so important to their work and to the discovery of promising cures and treatments.  

 

Stem cell surgery targets ALS Video

Patients glean hope from trial’s progress but wish it were faster

 

video-emerging-scholars-programDonors pitch in to keep brilliant science minds at U-M Video

Emerging Scholars program connects promising M.D.-researchers with philanthropists